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Incubation of luteal cells with human, horse and rat sera, but not bovine sera resulted in enhanced basal and hCG- 
stimulated progesterone accumulation. The stimulatory effect of human or rat sera on basal, hCG- or 8 Br-cyclic 
AMP-induced progesterone synthesis in luteal cells was evident within 15-30 min after incubation, reaching a 
maximum after 3-4 h. The stimulatory effects of hCG and/or sera were blocked by inhibitors of RNA and pro- 
tein synthesis. Similarly, lysosomotropic agents, chloroquine (100 PM) and ammonium chloride (10 mM), partly 
blocked the steroidogenic response of luteal cells to hCG and/or human or rat sera. Incubation of cells in the 
presence of 2deoxyglucose, sodium azide and phenylmethylsulfonyl fluoride resulted in partial inhibition of 
progesterone secretion in response to hCG or sera. Fractionation of human or rat sera into various lipoprotein 
fractions demonstrated that LDL and HDL most effectively supported and potentiated the steroidogenic response 
to hCG. Lipoprotein-deficient serum, however, did not alter gonadotropin-induced steroid production. Incuba- 
tion of luteal cells with increasing concentrations of h-LDL and h-HDL enhanced both basal and hCG-mediated 
steroidogenesis in a dose-related manner, although very high concentrations of these lipoproteins were tiibi- 
tory. Further, [ 3H]cholesterol from [ 3H Jcholesteryl linoleate-LDL was incorporated into luteal cell progesterone 
and the extent of this incorporation was enhanced by hCG. Addition of excess unlabeled h-LDL, h-HDL, as well 
as r-HDL, drastically reduced the incorporation of radioactive label into progesterone. These studies suggest that 
(a) serum potentiation of steroidogenesis was due to presence of lipoporteins, mainly LDL and HDL, and (b) the 
lipoprotein-bound cholesterol is delivered into the luteal cells and utilized for steroidogenesis. 
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Introduction 
The steroid-producing tissues, adrenals, testis and 
ovary, exhibit greater requirements for cholesterol 
compared to nonsteroid-secreting tissues. These tis- 
sues utilize cholesterol not only for membrane bio- 
genesis but also for steroid hormone production. In 
u ovary, cholesterol for steroidogenesis can be made 
available by three principle sources: (a) synthesis de 
novo from acetate [l-4], (b) hydrolysis of esterified 
cholesterol esters stored in lipid droplets [ 1,3,4], and 
bis(2-(S-pheny1oxazolyl)benzene. (c) uptake of preformed cholesterol from blood 
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[3,5]. Although these sources are capable of supply- 
ing cholesterol for steroidogenesis, their relative con- 
tribution and interrelationship under normal physio- 
logical conditions is not well understood at the 
present time. Further, while the initial events in 
gonadotropin-induced steroidogenesis including hor- 
mone binding and adenylate cyclase activation have 
been studied extensively in recent years [4,6,7], the 
precise knowledge of the role of precursor in the 
steroidogenic process is still fragmentary. 
Recently several investigators have demonstrated 
that lowering of blood cholesterol levels by the 
pharmacological agent, 4-aminopyrazolo[3,4-d]pyri- 
midine (4-APP), leads to a reduction in the circulating 
level of steroid hormones [8-l 1] . While these studies 
suggest a possible link between in vivo steroidogenesis 
and blood cholesterol levels, the 4-APP manipulation 
of cholesterol levels may not represent a true physio- 
logical situation and, thus, this still leaves an open 
question about the principal source of the substrate 
for steroidogenesis. Preliminary studies reported from 
this laboratory suggest that ~cubation of ovarian 
cells in the presence of fetal calf serum not only 
shifted the dose response curve for hCG and LH, but 
also led to enhanced maximal accumulation of 
progesterone [ 121. These observations prompted us 
to: (1) Determine the stimulatory effects of sera from 
different sources for steroidogenesis, (2) identify fac- 
tors from serum which cause stimulation of steroido- 
genesis and (3) study the extent of utilization and 
regulatory role of endogenous versus exogenous 
cholesterol in gonadotropin-induced steroidogenesis. 
Rat luteal cells prepared from highly luteinized 
ovaries [ 13,141 were used in the present studies. 
These cells are highly sensitive to physiological doses 
of gonadotropins and respond to LH/hCG with 
enhanced accumulation of cyclic AMP and progester- 
one. 
We report here that in luteal cells (a) sera from dif- 
ferent sources stimulated steroidogenesis in a time- 
and concentration-dependent manner, (b) the major 
stimulatory factors in serum were identified as LDL 
and HDL, (c) cholesterol from radioactively labeled 
h-LDL was incorporated into progesterone and (d) 
these cells are acutely dependent upon exogenous 
cholesterol source in the form of lipoproteins for 
maximum expression of steroidogenic response. 
Materials and Methods 
Materials 
Purified human choriogonadotropin (CR-1 19, 
11 500 I.U./mg) was generously supplied by Dr. R. 
Canfield, Columbia University, New York, through 
Population Research Branch, National Institutes of 
Child Health and Human Development, National 
Institutes of Health, Bethesda, MD. 8-Br-cyclic AMP, 
cyclic AMP and cyclic AMP-dependent protein kinase 
(beef heart) were obtained from Sigma Chemical Co., 
St. Louis, MO. I-Methyl-3.isobutylxanthine (MIX) 
and cyclic [8-3H]AMP (spec. act. 25 Cilmmol) were 
purchased from Aldrich Chemical Co., Milwaukee, 
WI, and ~ersh~/Searle, respectively. Collagenase 
(Type CLS) and deoxyribonuclease were supplied by 
Worthington Biochemical Corporation, Freehold, NJ. 
Medium log/Medium 199, fetal bovine and horse sera 
were products of Grand Island Biological Co., Grand 
Island, NY. Other reagents used were of analytical 
reagent grade. 
Me thuds 
Hormonal pretreament of rats. 22-24.day-old 
female rats, obtained from Spartan Research Animals, 
Inc., Hazlett, MI, were used in the present studies. 
Highly luteinized ovaries from these rats were ob- 
tained following the regimen described by Parlow 
[ 151. This involved subcutaneous injection with 50 
I.U. pregnant mare’s serum gonadotrop~ (Gesty, 
Organon, Oss, Holland) followed 56 h later by 25 I.U. 
of hCG (Sigma Chemical Co). on day 0. 
Preparation of luteal cells. 5-7 days after the 
injection of hCG, the animals were killed by cervical 
dislocation, the ovaries removed, freed of connective 
tissues, weighed and placed in Medium 109 contain- 
ing 0.1% bovine serum albumin. Collagenase-dispersed 
luteal cells were prepared by a slight modi~cation of 
the procedure described earlier by workers from this 
laboratory [ 13,141. Briefly, the ovaries were cut into 
small pieces (approximately 1 mm3) with scissors and 
transferred to a 50 ml plastic beaker. The tissue was 
suspended at a concentration of 50 mg/ml of Medium 
10910.1% bovine serum albumin containing 500 U/ml 
collagenase and 4 mg/ml DNAase. The samples were 
incubated for 60 min at 37°C in an atmosphere of 
OZ/COZ (95 : 5, v/v). At 30 and 60 min of incubation 
the cells were dissociated by flushing the tissue and 
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medium 30-40 times through a I ml plastic syringe. 
At the end of the incubation the cell suspension was 
diluted with 2 vol. of medium and centrifuged at 
600 Xg for 3 min. The sedlmented cells were washed 
two times in Medium 109/0.1% bovine serum albu- 
min and then resuspended to a concentration of 
approx~ately 1 * IO7 cells/ml. The viability of the 
cells ranged between 80-90% as ascertained by the 
trypan blue exclusion test. DNA was determined 
according to the procedure of Burton [ 161. 
Preparation of ovarian cells. Cells from whole 
ovaries of 24-26-day-old rats were prepared essen- 
tially as described previously by workers from this 
laboratory [ 17-201. Incubation conditions for the 
measurement of progesterone response were the same 
as described, below for Iuteal cells. 
Incubation conditions for progesterone measure- 
ment. Unless otherwise stated aliquots of luteal cells 
(approximately 2 * lo6 cells in 0.1 ml) were trans- 
ferred into 12 X 75 mm tubes containing 0.3 ml Medi- 
um 109/0.1% bovine serum albumin, and, where 
required, appropriate concentrations of various sera, 
hCG, or lipoproteins were also added. The incuba- 
tions were carried out at 37°C in a Dubnoff metabolic 
shaking incubator for 4 h in the presence of OZ/COZ 
(95 ‘: 5, v/v). F o 11 owing incubation, the reaction was 
stopped by placing the sample tubes in a boiling 
water bath for 3 mm. The samples were then diluted 
with 0.6 ml HZ0 and 10000 cpm [I ,2(n)-3H]proges- 
terone (spec. act 55 Ci/mol) were added to monitor 
progesterone recovery and the samples left in the cold 
overnight. Next morning the samples were extracted 
with light petroleum ether and assayed for progester- 
one by radioimmunoassay as described earlier [ I2,17, 
191. 
Measurements of cyclic AMP accumulation in 
Zuteal celk Luteal cells (approx. 2 . 106) were dis- 
persed in a final volume of 0.4 ml of Medium 1091 
0.1% bovine serum albumin, 0.5 mM MIX, and where 
required, 25 ng/ml hCG and various sera (25%, v/v). 
Following incubation, usually for 2 h, the reaction 
was stopped by placing tubes in a boiling water bath 
for 5 min and then transferred to ice. After 10 min, 
0.5 ml trichloroacetic acid (IO%, w/v) and 0.1 ml of 
cyclic f3H] AMP (approx. 2 000 cpm) were added and 
the samples stored overnight in the cold. After cen- 
trifugation at 3 000 Xg for 10 mm, the clear super- 
natants were processed and assayed far cyclic AMP 
by the procedure of Gilman [21] as described earlier 
ElSJ. 
Incorporation of /3H]cholesterol from /3H]- 
cholesteryl linoleate-hLDL into progesterone bJ 
Zuteal ceEls. Rat luteal cells (approx. 2 . 106) were 
incubated in a final volume of 1 ml of Medium 109 
containing 1 mgjml bovine serum ~bumin, 20 pg 
protein~ml f3H] ~holeste~l linoleate-hLDL (60 000 
cpm/nmol), cholesteryl linoleate and, where required, 
10 ng/ml hCG, 720 pg protein/ml h-LDH, 750 @g/ 
protein/ml h-HDL or 350 pg protein/ml r-HDL. After 
incubation for 4 h in an atmosphere of 02/C02 
(95 : 5), 1 ml phosphate-buffered saline was added to 
each tube and the tubes were transferred to boiling 
water bath for 3 min. ~~4C]Progesterone (50 irg, 
1000 cpm), 2O~-hydroxypregn4-en-3-one (50 pg) 
and pregnenolone (50 I.tg) were added as carriers and 
steroids were extracted two times with 5 vol. of light 
petroleum ether and two times with 5 vol. of ethyl 
acetate. The petroleum ether and ethyl acetate frac- 
tions were dried separately under Na. The residues 
from two fractions were dissolved in chloroforms 
methanol (2 : l), combined and redried under a 
stream of Nz_ The residues were dissolved in 3 ml of 
90% aqueous methanol and partitioned three times 
against 1 ml of hexane [10,22]. Steroids in the 
methanolic phase were separated by thin-layer 
chromatography using Silica Gel G glass plates. The 
plates were developed either one time in a solvent sys- 
tem of ~hloroform/dietllyl ether (9 : 1, v/v), 1211, 
three successive times in a system of isopropylether/ 
diethyl ether/acetic acid (70 : 30 : 2, v/v) [lo] or 
three times in a solvent system of isopropyl ether/ 
petroleum ether/acetic acid (70 : 20 : 1, v/v). 
Authentic standards, cholesteryl oleate, cholesterol, 
progesterone, 2&-hydroxypregn4en3-one and 
pre~~-S~n-3-01-2O-one, were always run simulta- 
neously and steroids were visualized by exposure to 
iodine vapor. The steroids were eluted in chloroform/ 
methanol (2 : 1) and counted for radioactivity deter- 
minations. In some cases separation of progesterone, 
pregnenolone, and 20ahydroxypregn4en3-one was 
achieved by thin-layer chromatography on plastic- 
backed Silica Gel G sheets using chloroform~diethyl 
ether (9 : 1) as a developing solvent system [23]. The 
spots were cut out and counted for radioactivity after 
the addition of PPO/POPOP-based scintillation fluid. 
Isolation of lipoproteins. Human VLDL (d < 
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1.006 g/ml) LDL (d = 1.02-10.5 g/ml), HDL (d = 
0.07-l 215 g/ml) and lipoprotein-deficient serum 
(d > 1.2 15 g/ml) were prepared by differential ultra- 
centrifugation, using KBr for density adjustments 
[24]. Human lipoprotein fractions were isolated from 
blood plasma from healthy donors and collected in 
0.1% EDTA. Rat lipoprotein fractions were isolated 
from pooled sera. Isolated fractions were concen- 
trated by recentrifugation at their respective densities 
at 45 000 rpm in a Ti 60 rotor for 24 h at 11 “C. Lipo- 
proteins were dialyzed for 36-48 h against three to 
four changes of 0.15 M NaCl containing 0.3 mM 
EDTA, sterilized by filtration through a 0.22 I.L~ 
Millipore falter and stored at 4°C until used. Immedi- 
ately prior to use, these fractions were dialyzed 
against 0.15 M NaCi to remove EDTA. Purity of lipo- 
protein fractions was checked by cellulose acetate 
[25] and agarose gel electrophoresis in 0.05 M barbi- 
tal buffer, pH 6.8, using precast (Bio-Gram A, BioRad 
Lab} agarose slides [26]. The mass ratio of total 
cholesterol to protein was 1.4 : 1 and 1 : 3.58 for 
human LDL and human HDL, respectively. Similarly, 
rat LDL and rat HDL had mass ratios of total choles- 
terol to protein of 1.3 : 1 and 1 : 1.6, respectively. 
Human LDL radioactively labeled with [ 3H] choles- 
teryl linoleate was prepared according to the proce- 
dure of Kreiger et al, [27]. Total plasma or serum 
cholesterol was determined by the procedure of Zak 
[28], For lipid analysis, lipids were extracted from 
lipoprotein fractions in chlorofo~~methanol (2 : 1, 
v/v) [29], Lipoprotein phospho~pid phosphorous was 
determined by the procedure described previously 
[30]. The relative contribution of individual phos- 
pholipids to total phospholipids and free cholesterol 
and cholester ester to total cholesterol was deter- 
mined after the separation of individual lipids by 
thin-layer chromatography [3 11. The separation of 
neutral lipids including cholesterol and cholesterol 
esters was accomplished by single-dimension, two- 
step development thin-layer chromatography [3 1] 
using isopropyl ether/acetic acid (96 : 4, v/v) as first 
developing solvent and petroleum ether/diethyl ether/ 
acetic acid (90 : 10 : 1, v/v) or diethyl etherlhexane 
(6 : 94, v/v) as second solvent. Cholesterol and cho- 
lesterol esters were eluted successively with diethyl 
ether (20 ml), chlorofo~~methanol (10 ml, 4 : 1, 
v/v) followed by chloroform/methanol (10 ml, 2 : 1, 
v/v). Cholesterol esters, after saponification in alco- 
holic KOH, and free cholesterol were quantitated by 
the calorimetric procedure of Zak [28] and, if neces- 
sary, by the micro method of Glick et al. [32]. Pro- 
tein content of lipoprotein was determined by a 
modification of the procedure of Lowry et al. [33] as 
described by Markwell et al, [34] _ 
Results 
Effect of different incubation media. Results 
presented in Table I demonstrate the effect of various 
incubation media and human sera on progesterone 
production in luteal cells in response to hCG. Expo- 
sure of luteal cells with hCG in Medium 109 (Eagles 
rn~irn~ essential medium with Earles salt) caused a 
6-7-fold increase in progesterone production. Simi- 
larly, gonadotropin incubation in Medium 199 also 
resulted in a 6-7-fold stimulation of progesterone 
accumulation, Since Medium 199 also contains 200 
ng/ml cholesterol it is clear that direct addition of 
steroid precursor in incubation medium had no effect 
on steroidogenesis. In contrast, direct addition of 
human (male) serum enhanced steroidogenesis almost 
2.fold over the values obtained without added serum 
and in the presence of hCG. The small difference 
between basal and hCG-stimulated steroid production 
in the presence of serum suggests that human serum 
contains endogenous LH type of activity, which is 
sufficient to stimulate steroidogenesis maximally. In 
some studies exogenously added hCG did not show 
any stimulatory effect on human serum-stimulated 
steroidogenesis, presumably due to very high endoge- 
nous levels of LH. By contrast, rat sera from 26.day 
old rats which contains comparatively lower amount 
of LH exhibited marked difference between basal and 
hCG-stimulated progesterone production (Table I). 
Effect of increasing concentrations of various sera, 
The results presented in Fig. I demonstrate the effect 
of increasing concentrations of human, horse and 
fetal bovine serum on luteal cell steroidogenesis. 
Addition of human or horse serum enhanced proges- 
terone accumulation in a concentration-dependent 
manner. Concentrations as low as 2.5% significantly 
enhanced steroid synthesis. Further increase in serum 
concentration resulted in enhanced steroidogenesis, 
the maximal effective serum concentration being 25- 
40%. At maximum effective concentrations, these 
two sera caused a net 2-fold increase in progesterone 
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TABLE I 
INFLUENCE OF THE COMPOSITION OF THE INCUBATION MEDIA ON GONADOTROPINSTIMULATED STEROID SYN- 
THESIS IN RAT LUTEAL CELLS 
Rat Iuteal cells from pseudopregnant rat ovaries were prepared in Medium 109/O. I% b&ne serum albumin as described in Materi- 
als and Methods. For experiment 1~ aliquots of cells (approx. 2 . IO?) in triplicate were suspended and washed three times by cerr 
trifugation either in Medium 109/O.l% bovine serum albumin or Medium 199/O.t% bovine serum albumin and finally suspended 
in respective media at a concentration of 2 * 10’ cell/ml. Aliquots of cells (0.1 ml) were incubated without or with hCG in a final 
volume of 0.4 ml of the media for 4 h in the presence of 02/CO2 (95: 5, v/v) at 34°C. For experiment 2, the cells were incubated 
with various sera in the presence and absence of hCE for 4 h at 34°C in the presence of 0z/C02 (95: 5, v/v). Other details were 
simifar to those described in iMateriaIs and Methods. The results are mean ?: S.E. of three separate experiments on rripiicate deter- 
minations. 
Additions 
A. Experiment 1 
Progesterone (ng/pg DNA) 
Basal hCG (10 ng/ml) 
.-.---- 
Luteal celis incubated in Medium ~09~0.1% bovine serum albumin 
Luteal cells incubated in Medium lW/O.l% bovine serum albumin 
B. Experiment 2 ~fncubations in Medium 109/0.1% bovine serum albumin) 
None 
Human serum (15%, v/v) 
Rat serum fls%, v/v) 
FetaI bovine serum (15%, v/v) 
- 
0.54 f 0.02 3.88 It 0.10 {P < 0.005) 
0.63 + 0.02 3.61 i 0.05 (P < 0.001) 
0.66 ? 0.09 3.24 2 0.07 fP < 0.00s) 
6.09 t 0.39 7.18 5 0.19 Q< 0.05) 
1.74 t 0.02 6.94 c 0.62 iP < 0.001) 
1.16 20.02 4.64 k 0.52 (P < 0.001) 
Fig. 1. Effect of increasing concentrations of human, horse 
and fetal bovine sera on progesterone synthesis in rat luteal 
cells. Aliquots of cells (approx. 2 e 106), in triplicate, were 
incubated with indicated (final) concentrations of human 
(o), horse (A) or fetal bovine (s) sera. Where required, hCG 
~~c~rn~l~~ion ~omp~red to values obtained with hCG 
alone, In contrast, fetal bovine serum was not very 
effective and caused a slight increase in progesterone 
production at a concentration of 3%50%. 
Effect of i~~bati~n time on sera, hCG- and 8 Br- 
cyclic ALP-sti~u~at~d st~r~ido~en~s~s in rat luteal 
and rat ovarian cells. The results presented in Fig. 2 
show the effect of increasing incubation time on 
luteal cell stero~do~enesis in response to different 
stimuli. The basal ~rod~ctioR of prog~steron~ rapidly 
increased after 30 min of incubation and ten 
increased slightly up to 3 h of incubation. Addition 
of hCG (IO nglml) alone showed a lag period of lo- 
15 min and the extent of stimulation of steroidogene- 
sis was enhanced in a tjme-dependent manner, reach- 
ing to maximum after 2-3 h of incubation. In&&n 
(10 ng~rn~) was also added. After incubation at 37°C in an 
atmosphere of O&Z02 (95 : 5, v/v) for 4 h, the samples were 
extracted with light petroleum ether and quantitated by 
radio~munoas~y. The results are expressed as ng progester- 
one. #g DNA-* f S.E. and corrected for the amount of 
progesterone, if any, present initially in the added sera. The 
results are mean of three separate exper~m~nts on duplicate 
determinations. 
l HUMAN SERUM + hCG 
8 B-CAMP+ RAT SERUM 
n 8 &-CAMP+ HUMAN SERUM 
l 8Br-cAMP(15mM) 
TIME (minutes) 
Fig. 2. Effect of increasing incubation time on human serum-, 
rat serum-, hCG- and 8 Br-cyclic AMP-stimulated progester- 
one accumulation in luteal cells. Aliquots of luteal cells 
(approx. 2. 106) were incubated with or without hCG (10 
ng/ml) 8 Br-cyclic AMP (1.5 mM) either in the absence or in 
the presence of rat or human sera (25%, v/v). Following 
incubation at 34°C for the indicated time points in an atmos- 
phere of O#Os (95 : 5, v/v), the samples were processed 
for progesterone measurements by radioimmunoassay. Other 
details were the same as described in Materials and Methods. 
The results are mean of three separate experiments on dupli- 
cate determinations. 
of 25% rat serum in the incubation medium greatly 
potentiated the accumulation of progesterone in 
luteal cells (Fig. 2). The stimulatory effect was evi- 
dent as early as 15-30 min after the addition of 
serum, both in the presence of absence of hCG, and 
continued to increase with increases in incubation 
time up to 180 mm of incubation. The rat serum, 
however, maximally stimulated steroidogenesis after 
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4 h of incubation (data not shown). Luteal cell 
incubation with human serum alone stimulated 
steroidogenesis in a biphasic manner. Initially, proges- 
terone accumulation increased linearly from 30 to 90 
mm and then synthesis abruptly increased at 2 h, and 
continued to rise up to 3 h. In contrast, addition of 
hCG along with human serum resulted in linear 
increase of steroid synthesis after 30 min up to 3 h 
of incubation. However, the stimulatory effect of 
hCG, at least in this instance, was observed only up to 
90 min. Further experiments were performed to 
ascertain if 8 Br-cyclic AMP-stimulated progesterone 
synthesis was potentiated by rat serum, to determine 
the locus of action of sera on the steroidogenic pro- 
cess. Exposure of luteal cells to 8 Br-cyclic AMP (1.5 
mM) caused a time-related increase in steroid synthe- 
sis and the extent of stimulation was comparable to 
that of hCG. Further addition of rat serum poten- 
tiated the 8 Br-cyclic action. These studies also sug- 
gest that serum stimulated steroidogenesis at a point 
distal to hormone-receptor interaction and cyclic 
AMP formation. 
Results presented in Fig. 3 demonstrate the action 
of human and rat sera on gonadotropin-stimulated 
progesterone accumulation in ovarian cells prepared 
from 26-day-old rats. Addition of human or rat sera 
greatly enhanced hCG-stimulated progesterone pro- 
duction. The stimulation of steroidogenesis by serum 
was seen from 30 to 240 min of incubation. These 
studies demonstrate that ovarian cells have the 
capability to respond to sera from different sources, 
with increased accumulation of steroid in response to 
hCG or LH. Further experiments were then carried 
out to explore the mechanism by which serum fac- 
tor(s) stimulate steroidogenesis. To accomplish these 
goals, luteal cells were utilized. The luteal cells were 
preferred, mainly due to the fact that (a) they are 
very sensitive to low physiological doses of LH/hCG, 
(b) they contain principally one cell type and (c) they 
secrete higher amounts of progesterone. 
Effect of inhibitors of RNA and protein synthesis. 
The inhibitors actinomycin D, cordycepin, cyclo- 
heximide and emetine were tested for their ability to 
inhibit steroidogenesis under basal conditions and in 
the presence of hCG, rat serum and rat serum plus 
hCG. The results of these experiments are presented 
in Table II. In general, these compounds inhibited 
steroidogenesis to the same extent regardless of the 
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60 120 180 240 
TIME (MINUTES) 
Fig. 3. Time-dependent effects of human serum, rat serum 
and hCG on progesterone synthesis in ovarian cells isolated 
from Xdayold rats. Aliquots -of ovarian cells (appros. 
2 * 106) were incubated with and without hCG (10 ng/ml) 
and/or rat serum. Other details were similar to those 
described in Fig. 2 and under Materials and Methods. The 
results are mean of four separate experiments on duplicate 
determinations. 
stimuli used for activation (e.g. hCG, serum, hCG t 
serum). Among these, cordycepin (250 @I) was least 
effective when added 30 min after the addition of 
stimuli. In general, protein synthesis inhibitors were 
more effective in blocking hormone- or serum- 
induced steroidogenesis. By contrast, preincubation 
of luteal cells with these inhibitors completely pre- 
vented the subsequent ability of the cells to respond 
to sera or hormones with increased accumulation of 
progesterone. 
The time-dependent effect of emetine under dif- 
ferent stimulatory conditions of steroidogenesis is 
shown in Fig. 4. As evident, these cells were very 
sensitive to emetine and addition of this inhibitor at 
time points between 10 and 15 mm blocked steroido- 
genesis in response to various stimuli. Thus, results 
presented in Table II and Fig. 4 suggest that, like 
basal and hCG-stimulated steroidogenesis, the serum- 
and serum plus hCG-stimulated steroid synthesis was 
also sensitive to RNA and protein synthesis inhibi- 
tors. Furthermore, the stimulatory effect of serum 
was due to an increase in the production of proges- 
terone and not due to decreased metabolisl~. 
Effect of ~soso~lotr~pic agents, metabolic inhibi- 
tors and protease inhibitors. The results presented so 
far suggest that stimulation of steroidogenesis by sera 
is mediated by an intracellular site of action, possibly 
by making available extra cholesterol substrate. Since 
TABLE II 
EFFECT OF MACROMOLECULAR SYNTHESIS INHIBITORS ON RAT SERUM-STIMULATED PROGESTERONE PRODUC- 
TION IN LUTEAL CELLS 
Incubation conditions were similar to those described in Fig. 2 except that the indicated concentrations of inhibitors were added 
30 min after the addition of hCG and/or serum. Total incubation time was 4 h. The results are t SE. of two separate experiments 
on triplicate determ~ations. 
- 
Inhibitors Progesterone (ngfpg DNA) 
-- 
Basal hCG Rat serum Rat serum + 
(10 ng/ml) (25% v/v) hCG (10 ng/ml) 
None 1.12t0.01 5.51 * 1.1 a 4.13 t 0.47 b 10.25 F 1.68 c 
Actinomycin D (IO&f) 0.76 + 0.08 2.17 + 0.04 1.73 i 0.16 5.41 + 0.52 
Cordycepin (250 ,uM) I .oo t 0.09 3.18 i 0.15 3.85 _+ 0.14 7.71 io.17 
Cycloheximide (5 0 PM) 0.70 fr 0.04 1.61 f 0.11 1.45 _c 0.21 2.5 7 + 0.06 
Emetine (10 gM) 0.69 f 0.01 1.14 f 0.06 1.32 + 0.08 1.68 t 0.19 








- t 29 
hCG (IO nglml) 
TIME (h) 
Fig. 4. Effect of addition of emetine at different time points 
on hCG- and rat serum-stimulated steroidogenesis in rat luteal 
cells. Incubation conditions were similar to that described in 
Fig. 2 except that at time points indicated by arrow 10 #M 
emetine was added and incubation continued for a total 
period of 4 h. The concentrations of hCG and rat serum used 
were 10 ngjml and 25% (v/v), respectively. The results are 
mean of two separate experiments on triplicate determina- 
tions. 
in many nonsteroidogenic cells [35-37,93 and 
human choriocarcinoma cells [38] cholesterol is 
delivered by LDL binding to cell surface receptors, 
followed by intern~ization and hydrolysis of choles- 
terol esters from the internalized lipoproteins by 
lysosomes, the present studies suggest that the mecha- 
nism of action of various inhibitors might be by 
inhibiting cellular endocytosis [39,40,36]. Exposure 
of luteal cells to lysosomotropic agents, chloroquine 
(100 @Q and ammonium chloride (10 mM) inhibited 
progesterone synthesis in response to rat serum and 
sera plus hormone (Table III). However, these inhibi- 
tors also inhibited steroidogenesis in response to hCG, 
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and slightly decreased the basal accumulation of 
progesterone. Similarly, metabolic inhibitors, 
2-deoxyglucose (10 mM) and sodium azide (10 mM), 
also affected the ability of luteal cells to respond to 
various stimuli. Sodium azide was most effective and 
completely blocked the hCG, rat serum and rat serum 
in the presence of hCG-stimulated steroid production 
(Table III). The presence of protease inhibitor, 
phenylmethylsulfonyl fluoride (2.5 mM), also 
resulted in the i~ibition of steroidogenic response. 
Lack of effect of various sera on ~~nad~trap~n 
stimulated cyclic AMP accumulation. The results of 
Table IV show a dose-dependent increase in cyclic 
AMP accumulation in response to hCG. However, 
unlike the steroidogenic action in luteal cell prepara- 
tions, addition of sera did not affect the basal or 
hCG-stimulated cyclic AMP synthesis. These results 
provide additional support that sera stimulate 
steroidogenesis at a point distal to hormone receptor 
~tera~tion and cyclic AMP fo~ation. 
Frac~o~atio~ of human plasma and rat serum into 
various lipoproteirz fractions. Human plasma and rat 
sera were fractionated into various lipoprotein frac- 
tions by differential ultracentrifugation. Results 
presented in Table V demonstrate the ability of 
VLDL, LDL, HDL and LPDS to modulate basal and 
hCG-stimulated progesterone accumulation, As 
expected, addition of human and rat serum poten- 
tiated steroid synthesis over that observed in the pres- 
ence of hCG alone. Addition of h-VLDL and, to some 
extent, r-VLDL resulted in stimulation of basal 
steroid synthesis. These lipoproteins, however, were 
without any effect on hCG-induced progesterone 
accumulation. Exposure of luteal cells to h-LDL and 
h-HDL not only stimulated basal but also greatly 
potentiated the hCG-stimulated progesterone accu- 
mulation (Table V). Addition of isolated r-LDL and 
r-HDL also enhanced basal and hCG-induced steroido- 
genesis to varying extents. The human LPDS fraction 
which was devoid of lipoproteins had no significant 
effect. These results suggest that the stimulatory fac- 
tors present in serum constitute LDL and HDL and 
that the luteal cells have unique ability to utilize lipo- 
protein-delivered cholesterol for steroidogenesis. 
Further, unlike in other systems [ 10,37,9,41], these 
ceils have the ability to utilize lipoproteins (LDL and 
HDL) for steroidogenesis ~mediately after their 
isolation, with no apparent need for prolonged incu- 
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TABLE III 
EFFECT OF LYSOSOMOTROPIC AGENTS, METABOLIC INHIBITORS AND PROTEASE INHIBITOR ON hCG- AND SERA- 
STIMULATED PROGESTERONE PRODUCTION IN RAT LUTEAL CELLS 
Rat iuteat cells (approx. 2 . 106) were incubated with rat serum, human serum or hCG either in the presence or in the absence 
of indicated concentration of various inhibitors for 4 h. Other details are similar to those described in Fig. 2. The results are 
mean It SE. of four separate experiments on duplicate determinations. 






Human serum Rat serum Human serum 
(25%) + hCG f hCG 
None 
Chloroquine (100 PM) 
Ammonium chloride (10 mM) 
2-Deoxyglucose (10 mM) 
Sodium azide (10 mM) 
Phenylmethylsulfonyl fluoride 
(2.5 mM) 
0.81 k 0.02 3.48 _+ 0.06 2.64 _t 0.03 6.10+0.12 5.62 -f: 0.04 5.64 k 0.07 
0.76 + 0.01 2.46 t 0.08 1.8 kO.09 4.72 t 0.12 3.96 t 0.05 4.10 f 0.06 
0.79 * 0.04 2.88 t 0.04 2.30 + 0.02 4.22 + 0.08 4.36 IO.05 4.0 k 0.03 
0.78 k 0.01 2.96 1.0.05 1.6 k 0.06 3.54 + 0.12 3.68 rt 0.09 3.88 5 0.17 
0.41 + 0.03 0.40 t 0.01 0.71 * 0.01 0.90 + 0.06 0.88 rt 0.03 0.82 k 0.08 
0.74 _+ 0.05 0.91 _+ 0.02 1.32 k 0.06 1.82 Ir 0.13 2.76 It 0.09 2.60 f 0.13 
TABLE IV 
LACK OF EFFECT OF VARIOUS SERA ON CYCLIC AMP 
PRODUCTION IN RAT LUTEAL CELLS IN RESPONSE 
TO hCG 
Rat luteal cells (approx. 2. 106) were exposed to the indi- 
cated concentrations of hCG, human, horse or rat sera in 0.4 
ml Medium 109 con~inin8 1 m~ml bovine serum atbum~ 
and 0.5 mM MIX. After incubation at 34°C for 2 h in the 
presence of Oz/C02 (95 : 5, v/v) the sampIes were processed 
and assayed for cyclic AMP as described in Materials and 
Methods. The results are meant S.E. of three separate 
experiments on duplicate determinations. n.s., not signifi- 
cant. 
- 
Additions Cyclic AMP 
(pmoI/~g DNA) 
Basal 2.08 f 0.21 
Human serum 2.21 k 0.27 (ns.) 
Horse serum 2.07 + 0.15 (ns.) 
Fetal bovine serum 2.16 + 0.19 (n.s.) 
Rat serum 2.04 5 0.09 (ns.) 
hGC (0.1 ngjml) 2.45 + 0.10 (P < 0.05) 
hCG (1 ngjml) 5.50 * 0.46 (P < 0.005) 
hCG (10 ng/ml) .7.62 k 0.54 (P < 0.001) 
hCG (25 ngfml) 8.47 ? 0.58 (P < 0.001) 
Human serum + hCG (0.1 ng/ml) 3.16 i- 0.17 (P < 0.01) 
Human serum + hCG (1 ng/ml) 4.52 f 0.28 (P < 0.005) 
Human serum + hCG (10 ng/ml) 7.83 + 0.19 (P < 0.001) 
Horse serum + hCG (10 ng/ml) 7.41 k 0.45 (P < 0.005) 
Fetal bovine serum + hCG 
(10 ng/ml) 
Rat serum + hCG (10 ng/ml) 
7.80 f 0.44 (P < 0.005) 
6.98 + 0.29 (P < 0.001) 
bation in lipoprotein-free medium. 
Effect of increasing concentrations of h-LDL and 
h-HDL. The effect of exposure of luteal cells to 
increasing concentrations of h-LDL and h-HDL on 
steroidogenesis is shown in Fig. 5 (A, B). Addition of 
h-LDL from 25 ~18 protein~ml up to 400 I.rg protein,’ 
ml enhanced basal and hC~-stimulated progesterone 
accumulation in an almost linear manner. Higher con- 
centrations of h-LDL, from 1600 pg protein/ml up 
to 2 800 pg protein/ml, were inhibitory (Fig. SA). 
Results presented in Fig. 6B demonstrate the dose- 
dependent effect of h-HDL on steroidogenesis. Basal 
steroidogenesis was rn~~a~y stimulated in the pres- 
ence of 100-200 ct% proteinjml of h-HDL and then 
remained constant up to 2 800 pg protein/ml. In con- 
trast, h-HDL potentiated hC!G-induced steroidogene- 
sis maximally at around 800 ~18 protein/ml. As in the 
case of LDL, higher concentrations (1600-2 800 hg 
protein/ml) led to inhibition of steroid accumulation 
(Fig. 5B). 
Actions of h&DA and h-HDL on &real ceil sfe- 
roidog~nesis in response to increasing concent~a~‘ons 
of gonadotropin. Results shown in Fig. 6 demonstrate 
luteal cell sensitivity to increasing concentrations of 
hCG. Concentrations of hCG as low as 0.01 ng/ml 
significantly stimulated progesterone synthesis and 
this effect was increased with increases in gonado- 
tropin concentration, reaching a maximum between 
TABLE V 
EFFECT OF VARIOUS LIPOPROTEIN FRACTIONS, 
HUMAN AND RAT SERA ON GONADOTROPIN-STIMU- 
LATED PROGESTERONE ACCUMULATION IN LUTEAL 
CELLS 
Incubation conditions were identical to those described in 
Fig. 2 except that the indicated concentrations (&g choles- 
terol/ml) of various lipoprotein fractions. various sera or hCG 
(10 ng/mi) were also added. Other details were simikr to 
those described in Materials and Methods. The results are 
mean 5 S.E. of four separate experiments on triplicate deter- 
minations. n.s., not significant. 
Additions Progesterone (ng/pg DNA) P 
Basal hCG(10 ng/mi) 
None 0.81 t 0.03 4.4 It 0.18 <O.OOl 
h-VLDL 
(5 0 pglml) 2.12 _c 0.12 4.25 + 0.15 <O.OlO 
h-LDL 
(930 &ml) 1.82 L 0.08 10.35 f 0.35 <O.OOl 
h-HDL 
(210 yg/ml) 1.44 -+ 0.09 7.65 + 0.24 <o.oos 
r-VLDL 
(60 pgi’ml) 1.06 t 0.04 4.45 4 0.21 <0.005 
r-LDL 
(75 0 pg/ml) 1.18 + 0.06 5 65 f 0.09 <0.02 
r-HDL 
(600 fig/ml) 1.53 zt 0.03 7.06 + 0.11 <O.OOl 
h-LDPS 
(254, v/v) 4.47 t 0.07 4.65 + 0.19 n.s. 
Human (male) 
serum (2X&, v/v) 1.4 1 i; 0.29 8.5 7 + 0.45 <0.05 
Rat serum 
(25%, v/v) 2.24 f 0.38 8.51 -f 0.41 <0.005 
0.5 and 1 ngjml. The concentration of hCG required 
for half-max~al stimulation of steroidogenesis 
(ED& was calculated to be 0.03 ng/ml. Addition of 
h-LDL or h-HDL potentiated the response at all the 
concentrations of hCC tried. The EDSo of hCG in the 
presence of h-LDL and h-HDL were calculated to be 
0.012 and 0.015 ng/ml, respectively. 
Incorporation of f ‘~/cho~estero~ from f3H/- 
c~oleste~~-lino~e~te-h-LDL in to &teal progesterone. 
Further experiments were performed to demonstrate 
the utilization of lipoprotein-bound cholesterol as 
substrate for steroidogenesis. For these experiments, 
48/;;---- 
400 800 1200 1600 2000 24400 2800 
h- HDL (~0 Prolain/ml) 
Fig. 5. Effect of increasing concentrations of human LDL 
and HDL on choriogonadotrop~-stimu~ted progesterone 
accumulation. Rat luteal cells (approx. 2 . 106) were incu- 
bated with the indicated concentrations of LDL (A) or HDL 
(B) in the presence (A) and absence (A) of hCG (10 ng/ml). 
After incubation at 34°C for 4 h in the presence of O&Oz 
(95 : 5, v/v), the samples (medium + cells) were extracted 
with light petroleum ether and progesterone was measured 
by radioimmunoassay. Results are mean of three separate 
experiments on duplicate determ~ations. 
h-LDL-sterol esters were replaced with [%]choles- 
teryl-linoleate according to the procedure of Krieger 
et al. [27 1. Following incubation of luteal cells with 
[3H]cholesteryl-linoleate-h-LDL in the presence and 
absence of hCG, the radioactively labeled progester- 
one was separated by thin-layer chromato~aphy. 
Results presented in Table VI demonstrate the con- 
siderable radioactivity originally present in tritiated 
h-LDL was incorporated into the luteal cell proges- 
Fig. 6. Effect of human LDL and HDL on progesterone syn- 
thesis in luteal cells in response to increasing doses of hCC. 
Incubation conditions were identical to those described in 
Fig. 2 except that the indicated ~oncentratjons of hCG in the 
presence (0, A) and absence (0) of lipoproteins were also 
added. Other details were similar to those described in 
Materials and Methods. The results are mean of three separate 
experiments on duplicate determinations. 0, h-HDL (800 &g 
protein/ml); a, h-LDL (700 pg protein/ml). 
terone. The incorporation of radioactivity into 20a- 
hydroxy-pregn4en3-one and pregnenolone com- 
pared to progesterone were 47 2 9 and 11 i: 4%, 
respectively. However, since progesterone is a major 
steroid produced in the lute+ cells in response to 
hCG, data dealing only with radioactivity incorpora- 
tion into this product are presented. Exposure of 
luteal cells to 3H-labeled h-LDL in the presence of 
hCG further enhanced S-7-fold the incorporation of 
radioactivity into progesterone. Addition of excess 
TABLE VI 
INCORPORATION OF 13H]CHOLESTEROL FROM [3H]- 
CHOLESTERYL-LINOLEATE-hLDL INTO PROGESTER- 
ONE BY LUTEAL CELLS 
incubation conditions were similar to those described in 
Materials and Methods except that the indicated concentra- 
tions of unlabeled lipoproteins were also added. Thin-layer 
plates (Silica Gel G) were developed in a solvent system of 
chloroform/diethyl ether (9 : 1. v/v) and three successive 
developments in isopropyl etherldiethyl ether/acetic acid 
(70 : 30 : 2, v/v). The results are mean f SE. of three sepa- 
rate experiments. Experiments 1 and 2 were carried out with 
two different preparations of [sH]cholesteryl-linoleate- 
hLDL. 
~____ 
Additions [3H~Progesterone (pmol radio- 
activity incorporated/fig DNA) 
Experiment 1 Experiment 2 
~- 
Basal 0.199 i 0.01 0.141 io.011 
hCG ( 10 ng/ml) 0.872 + 0.038 * 0.890 i 0.018 b 
h-LDL 
(720 pg protein/ml) 0.025 _+ 0.007 0.017 rt 0.003 
h-LDL f hCG 0.134 5 0.010 0.146 t 0.023 
h-HDL 
(750 ~g protein/ml) 0.018 i 0.002 0.014 t 0.003 
h-HDL + hCG 0.145 fO.O1l 0.130 i 0.005 
r-HDL 
(380 pg protein~ml) 0.040 f 0.006 0.024 t 0.002 
r-HDL + hCG 0.170 + 0.010 0.155 + 0.013 
-__I 
ap < 0.005. bP < 0.001. 
unlabeled h-LDL, or r-HDL drastically reduced the 
extent of radioactivity incorporation into progester- 
one, thus suggesting that various lipoproteins could 
supply cholesterol to luteal cells for steroidogenesis, 
possibly through a receptor-mediated event(s). 
Discussion 
The present studies were performed to examine 
the mechanism involved in serum stimulation of 
steroidogenesis and to study the regulatory role of 
plasma lipoproteins in gonadotropin-induced ste- 
roidogenesis in luteal cells. Exposure of rat luteal cells 
to various sera enhanced the ability of these cells to 
produce more progesterone under basal conditions as 
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well as in response to gonadotropin. Although con- 
siderable species variation was observed among the 
sera tested, with the exception of fetal bovine serum, 
all other sera st~ulated steroidogenesis in a time- and 
concentration-dependent manner. Often the stimula- 
tory effect of hCG was not seen when cells were 
exposed to this hormone along with human or horse 
sera, although the net accumulation of progesterone 
was at least 2-2.5fold higher than that seen in the 
presence of hCG alone. The lack of stimulatory effect 
of hCG in the presence of human or rat sera might be 
due to the fact that the steroidogenesis may be maxi- 
mally stimulated by the endogenous LH in these 
prep~ations. By contrast, addition of rat serum from 
prepubertal rats, which contained comparatively 
lower amounts of LH, potentiated the stimulatory 
effect of hCG. Exposure of luteal cells to human, rat 
or fetal bovine sera neither stimulated basal produc- 
tion nor modified hCG-stimulated cyclic AMP accu- 
mulation. This lack of stimulation of cyclic AMP 
accumulation is not surprising in view of the data 
presented in Table IV and Fig. 6 in this communica- 
tion as well as the studies reported earlier [12,14] in 
which the optimum concentration of trophic hor- 
mone required for maximum accumulation of cyclic 
AMP was much higher (lo-25-fold) than that needed 
for maximum expression of steroidogenesis. This 
situation becomes clearer if one considers the effect 
of various sera on steroidogenesis in two different cell 
types (ovarian cells from immature rats vs. luteal 
cells) of ovarian origin as shown in Figs. 2 and 3. The 
whole ovarian cell suspension prepared from ovaries 
of 26-day-old rats responded to hCG which was fur- 
ther potentiated by human and rat sera. Unlike luteal 
cells, these cells require higher concentrations of hCG 
[ 12,141; thus, the low endogenous LH present in the 
sera was not sufficient to stimulate steroidogenesis 
maximally. The rat serum which contained the lowest 
level of endogenous LH produced only a slight 
increase in basal steroid production, althou~ it po- 
tentiated hCG-stimulated steroidogenesis as effec- 
tively as human serum. Further, the lack of stimula- 
tory effect of various sera on luteal cyclic AMP pro- 
duction as well as their ability to potentiate 8 
Br-cyclic AMP-stimulated steroidogenesis suggests 
that their site of action lies at a step beyond hormone 
receptor interaction and cyclic AMP formation. 
To elucidate further the mechanism of stimulatory 
action of varous sera, we examined the effects of 
RNA and protein synthesis inhibitors, lysosomotropic 
agents, metabolic inhibitors and protease inhibitors 
on luteal cell steroidogenesis in response to hCG and/ 
or sera. Actinomycin D, cycloheximide and emetine 
all blocked steroidogenic response to hCG. These 
results are in agreement with those reported earlier 
from this laboratory on gonadotropin-induced proges- 
terone synthesis in rat ovarian cells [13], althou~ in 
the present experiments these inhibitors also blocked 
serum-stimulated steroidogenic response. These 
results thus reflect a general requirement for RNA 
and protein synthesis that was not limited to ste- 
roidogene~s st~mu~ted by the addition of sera. The 
possibility that serum stimulation of steroidogenesis 
involves uptake and utilization of serum cholesterol 
for steroid synthesis was ascertained by the use of 
lysosomotropic agents, metabolic and protease inhibi- 
tors. All these agents ~hibited the steroidogenetic 
response to hCG and/or sera. Since these inhibitors 
partially blocked steroidogenesis in the presence and 
absence of serum and in response to various stimuli, it 
is concluded that their ability to inhibit steroidogene- 
sis was not entirely related to their ability to modu- 
late luteal cell cholesterol uptake from the sera, 
although the exact mechanism is still unknown. It has 
been reported that these agents inhibit Leydig tumor 
cell steroidogenesis in response to various stimuli 
[42]. Similarly, lysosomotropic agents have been 
shown to block steroidogenic response of ovarian 
cells to LH and dibutyryl cyclic AMP [43]. 
Using differential ultracentrifugation technique, 
the stimulatory factors in human and rat serum were 
identified mainly as HDL and LDL. In fact, exposure 
of luteal cells to LDL or IF-IDL in the presence of hCG 
seemed to reproduce the stimulatory effect seen with 
sera. It is of interest to note that luteal cells appear to 
be unique among various steroid-producing cells [lo, 
37,44,38] in their ability to take up and utilize lipo- 
proteindelivered cholesterol for steroid synthesis 
without any apparent need for culture and prolonged 
incubation in lipoprotein-deficient medium. Thus, in 
contrast to cultured mouse adrenal Y-l cells [37], 
cultured bovine adrenocortical cells 1441, cultured rat 
granulosa cells [lo], and cdtured human choriocar- 
cinema cells [38], the luteal cells possess a unique 
capability to metabolize and incorporate lipoprotein- 
delivered cholesterol into progesterone, almost 
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immediately after their isolation from luteinized 
ovaries. Among various lipoproteins tested, LDL and 
HDL most effectively supported hCG-stimulated 
steroidogenesis. Further, luteal cells exhibited the 
ability to utilize these lipoproteins either from 
homologous (rat serum) or heterologous sera (human 
plasma) and provide a substrate for steroidogenesis. 
VLDL, while failing to potentiate hCG-stimulated 
steroid accumulation, did stimulate basal production 
of progesterone. Since VLDL has been shown to con- 
tain some cholesterol esters 145,461, it is quite likely 
that this Iipoprotein could deliver a limited amount 
of substrate sufficient to stimulate only basal ste- 
roidogenesis. 
The ability of luteal cells to utilize either LDL or 
HDL make them quite distinct from other steroid- 
secreting cultured cells [37,44,38], with the excep- 
tion of cultured rat granulose cells [lo]. In these sys- 
tems (37,38,44], LDL was shown to be the only 
lipoprotein responsible for providing a substrate for 
steroidogenesis. In cultured adrenal [37,44] and 
human choriocarcinoma cells [41], specific binding 
of 12sI-labeled LDL on the cell surface was shown to 
be displaced in the presence of unlabeled LDL and 
not very effectively by HDL. While these results 
strongly support the possibility that the adrenal sys- 
tem derives cholesterol from LDL, recent reports do 
not entirely support this assumption [8,9]. The 
extensive in vivo studies reported by Anderson and 
Dietschy [8] suggest that the three rat steroidogenic 
tissues, adrenal gland, ovary and testis, preferentially 
take up and utilize HDL rather than LDL. In con- 
trast, mouse adrenal glands were shown to obtain 
cholesterol from two lipoprotein systems, one spe- 
cific for LDL and the other for HDL [9]. The evi- 
dence presented in this study as well as that reported 
for cultured granulose cells [IO] suggest that either 
LDL or HDL supports steroidogenesis in ovarian cells, 
although not to the same extent. For example, if one 
expresses the results on the basis of the ratio of cho- 
lesterol to protein, then HDL seems to be the pre- 
ferred lipoprotein. However, assuming that 1 mol of 
human LDL contains 1 9 IO6 g of cholesterol and 
each mol of human HDL contains 3.7 * IO4 g of cho- 
lesterol [ 10,471 then, on a molar basis, LDL seems to 
be more effective in providing substrate for ovarian 
steroidogenesis. Similarly, in cultured granulosa cells 
on a molar basis, the concentration of HDL required 
to produce 50% inhibition in [14C]acetate incorpora- 
tion into cellular free sterols was shown to be 200- 
fold higher than the concentration of LDL required 
to produce similar inhibitiotl. ~~0~~ in the present 
studies we have investigated the mechanism(s) by 
which lipoprotein-bound cholesterol is delivered into 
the cells, previously it has been shown that porcine 
granulosa cells [48] and bovine granulosa cells [49] 
possess specific receptors for HDL and LDL, respec- 
tively. Studies are currently in progress to delineate 
whether luteal cells obtain cholesterol from lipopro- 
tein by a receptor-mediated process and, if so, 
whether HDL and LDL have specific receptors or 
share a common receptor site on the cell surface. 
In summary, the present studies demonstrate the 
ability of sera from different sources to stimulate 
steroidogenesis by delivering cholesterol (substrate) 
into luteal cells in the form of HDL and LDL. 
Further, luteal cells were found to have an acute 
requirement for exogenous cholesterol source in the 
form of plasma Iipoproteins for the maximum expres- 
sion of steroidogenesis. 
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